Thumb arthritis, a debilitating condition affecting the carpometacarpal (CMC) joint of the thumb, is emerging as a critical focus in orthopedic and rheumatology markets. Characterized by pain, stiffness, and reduced grip strength, this condition primarily impacts adults over 50, with osteoarthritis being the most common cause. As global populations age and lifestyle factors (e.g., repetitive hand use, joint stress) increase risk, the thumb arthritis market is projected to grow at a CAGR of 5.8% from 2024 to 2030, according to industry analysts. This expansion is fueled not only by rising prevalence but also by advancements in targeted therapies and a shift toward patient-centric care models.

The aging demographic is a key driver. By 2030, the global population aged 65+ is expected to reach 1.5 billion, with thumb arthritis prevalence increasing by 2% per decade in this group. In the U.S., 30% of adults over 65 report thumb joint issues, while Japan—with its elderly population exceeding 29%—has seen a 15% surge in diagnosed cases since 2020. Additionally, heightened awareness, driven by campaigns from groups like the Arthritis Foundation, has encouraged earlier seeking of treatment. Clinics now report a 25% increase in patients visiting with early-stage symptoms, up from 10% a decade ago.

However, the market faces challenges. Misdiagnosis remains common, as thumb arthritis symptoms overlap with other conditions like tendinitis or rheumatoid arthritis. A 2024 study in The Journal of Hand Surgery found that 40% of initial diagnoses were incorrect, delaying effective treatment. Furthermore, access to specialized care is limited in rural areas, where orthopedic specialists are scarce. These gaps create opportunities for innovative diagnostics and remote care solutions, which could bridge the divide between urban and rural patients.

Looking ahead, the market’s growth hinges on addressing these challenges and capitalizing on emerging therapies. From biologic drugs to 3D-printed splints, stakeholders are investing in solutions that improve outcomes and reduce costs. For businesses and researchers aiming to align with this trajectory, Market Research Future’s Thumb Arthritis Treatment and Growth Forecast Report offers granular data on regional prevalence, therapy adoption rates, and unmet needs, ensuring no stakeholder is left behind in this expanding market.